Top Markets
Coin of the day
China Resources Boya Bio-pharmaceutical Group Co., Ltd. China Resources Boya Bio-pharmaceutical Group Co., Ltd.

China Resources Boya Bio-pharmaceutical Group Co., Ltd.

300294
株式のランク #9112
Established in 1993 and headquartered in Fuzhou, China, China Resources Boya... Established in 1993 and headquartered in Fuzhou, China, China Resources Boya Bio-pharmaceutical Group Co., Ltd. (formerly Boya Bio-pharmaceutical Group Co., Ltd.) is a comprehensive pharmaceutical enterprise operating across China. The company is engaged in the research, development, production, and sale of a diverse portfolio, primarily focusing on blood products, diabetes medications, and various biochemical and chemical pharmaceuticals. Its extensive range of blood-derived products includes human fibrinogen, human albumin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, and freeze-dried intravenous human immunoglobulin. For diabetes management, the company offers metformin hydrochloride (both tablets and enteric-coated versions), pioglitazone hydrochloride dispersible tablets, glimepiride tablets, and calcium dobesilate capsules. Additionally, it produces specialized injections such as compound osteotide, oxytocin, and heparin sodium, which are utilized across numerous medical fields, including general medicine, hepatitis treatment, gynecology, and immunomodulatory applications.
株価
$2.16
最終同期: 2026-08-28
時価総額
$1.09B
変化(1日)
-0.07%
変化(1年)
-42.06%
CN
取引 China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294)

カテゴリー

China Resources Boya Bio-pharmaceutical Group Co., Ltd.(300294)の株価履歴
終値の最高値: $2.22 (2026-08-01)

終値の最安値: $1.36 (2012-03-01)
China Resources Boya Bio-pharmaceutical Group Co., Ltd. の株価履歴(2012 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -11.03%
2025 -22.56%
2024 -11.80%
2023 -2.68%
2022 -17.73%
2021 8.25%
2020 24.02%
2019 5.57%
2018 -8.13%
2017 -16.39%
2016 34.70%
2015 68.02%
2014 43.01%
2013 67.86%
2012 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH